HALO - Halozyme Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HALO is currently covered by 11 analysts with an average price target of $76.96. This is a potential upside of $7.24 (-5.65%) from yesterday's end of day stock price of $81.57.

Halozyme Therapeutics's activity chart (see below) currently has 179 price targets and 151 ratings on display. The stock rating distribution of HALO is 37.04% HOLD, 59.26% BUY and 3.7% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 82.01% with an average time for these price targets to be met of 243.06 days.

Highest price target for HALO is $93, Lowest price target is $56, average price target is $76.96.

Most recent stock forecast was given by from MORGAN STANLEY on 12-May-2026. First documented stock forecast 12-Jun-2014.

Best performing analysts who are covering HALO - Halozyme Therapeutics:

Jim Birchenough Jason Butler Brendan Smith Mitchell Kapoor Vikram Purohit

Currently out of the existing stock ratings of HALO, 10 are a HOLD (37.04%), 16 are a BUY (59.26%), 1 are a SELL (3.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Aug-2025

$93

$18.04 (24.07%)

$79

1 months 26 days ago
(12-May-2026)

11/12 (91.67%)

$22.07 (31.12%)

270

Hold Since 13-Jan-2025

$75

$0.04 (0.05%)

$65

4 months 19 days ago
(19-Feb-2026)

9/10 (90%)

$2.96 (4.11%)

291

Buy Since 24-Sep-2025

$90

$15.04 (20.06%)

$90

4 months 19 days ago
(19-Feb-2026)

10/12 (83.33%)

$17.96 (24.93%)

286

Buy Since 29-Feb-2024

$90

$15.04 (20.06%)

$79

6 months ago
(08-Jan-2026)

7/8 (87.5%)

$17.87 (24.77%)

209

Buy Since 24-Jul-2023

$90

$15.04 (20.06%)

$90

6 months 19 days ago
(19-Dec-2025)

32/38 (84.21%)

$22.65 (33.63%)

177

Show more analysts

Please expand the browser size to see the chart

What is HALO (Halozyme Therapeutics) average time for price targets to be met?

On average it took 243.06 days on average for the stock forecasts to be realized with a an average price target met ratio 82.01

Which analyst has the current highest performing score on HALO (Halozyme Therapeutics) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the most public recommendations on HALO (Halozyme Therapeutics)?

Jim Birchenough works at WELLS FARGO and has 3 price targets and 5 ratings on HALO

Which analyst is the currently most bullish on HALO (Halozyme Therapeutics)?

Vikram Purohit with highest potential upside - $18.04

Which analyst is the currently most reserved on HALO (Halozyme Therapeutics)?

Eun Yang with lowest potential downside - -$54.82

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?